Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Metastasis02:30

Metastasis

5.9K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.9K
Liver Regeneration01:24

Liver Regeneration

3.5K
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
3.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Altered Thymopoiesis in Thymoma Is Associated with Defects in Negative Selection Machinery and Decreased Treg Abundance.

Cancer immunology research·2025
Same author

Noninvasive Multicancer Detection Using DNA Hypomethylation of LINE-1 Retrotransposons.

Clinical cancer research : an official journal of the American Association for Cancer Research·2024
Same author

Ablation of FAS confers allogeneic CD3<sup>-</sup> CAR T cells with resistance to rejection by T cells and natural killer cells.

Nature biomedical engineering·2024
Same author

Protective effect of TCR-mediated MAIT cell activation during experimental autoimmune encephalomyelitis.

Nature communications·2024
Same author

MAIT cells: Conserved watchers on the wall.

The Journal of experimental medicine·2024
Same author

MAIT cells monitor intestinal dysbiosis and contribute to host protection during colitis.

Science immunology·2024

Related Experiment Video

Updated: Oct 27, 2025

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula
09:03

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula

Published on: January 26, 2024

538

Fighting Liver Metastasis by Activating MAIT Cells.

Olivier Lantz1

  • 1INSERM U932, PSL University, Institut Curie, Paris, France. Olivier.lantz@curie.fr.

Cancer Immunology Research
|July 22, 2021
PubMed
Summary

Mucosal-associated invariant T (MAIT) cells, when stimulated with antigen and a TLR9 ligand, reduce liver tumor growth. This suggests MAIT cells show promise as a novel antitumor immunotherapy tool.

Area of Science:

  • Immunology
  • Oncology
  • Hepatology

Background:

  • Mucosal-associated invariant T (MAIT) cells are a unique population of immune cells with potential roles in host defense and disease.
  • Intrahepatic tumor growth presents a significant challenge in oncology, necessitating novel therapeutic strategies.

Purpose of the Study:

  • To investigate the potential of MAIT cells as an antitumor agent in the context of intrahepatic tumors.
  • To evaluate the effect of antigen stimulation of MAIT cells in combination with TLR9 ligand CpG on tumor growth.

Main Methods:

  • Antigen stimulation of MAIT cells.
  • Administration of TLR9 ligand CpG.
  • Assessment of intrahepatic tumor growth in a preclinical model.

More Related Videos

Experimental Metastasis and CTL Adoptive Transfer Immunotherapy Mouse Model
08:06

Experimental Metastasis and CTL Adoptive Transfer Immunotherapy Mouse Model

Published on: November 26, 2010

19.8K
Murine Model of Metastatic Liver Tumors in the Setting of Ischemia Reperfusion Injury
05:59

Murine Model of Metastatic Liver Tumors in the Setting of Ischemia Reperfusion Injury

Published on: August 30, 2019

12.0K

Related Experiment Videos

Last Updated: Oct 27, 2025

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula
09:03

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula

Published on: January 26, 2024

538
Experimental Metastasis and CTL Adoptive Transfer Immunotherapy Mouse Model
08:06

Experimental Metastasis and CTL Adoptive Transfer Immunotherapy Mouse Model

Published on: November 26, 2010

19.8K
Murine Model of Metastatic Liver Tumors in the Setting of Ischemia Reperfusion Injury
05:59

Murine Model of Metastatic Liver Tumors in the Setting of Ischemia Reperfusion Injury

Published on: August 30, 2019

12.0K

Main Results:

  • Antigen stimulation of MAIT cells in the presence of CpG significantly decreased intrahepatic tumor growth.
  • These findings highlight a specific immunomodulatory effect of MAIT cells against liver tumors.

Conclusions:

  • MAIT cells, when appropriately activated, can serve as a potent tool against intrahepatic tumors.
  • This study provides a rationale for exploring MAIT cell-based immunotherapies for liver cancer.